4
Changes in Ownership
Retension Pharmaceuticals, Inc. Filed Acc 0001213900-26-108188
Options or other derivatives
- Director acquired 5,636 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BERGER FRANKLIN M Director | 2026-10-08 | Grant or award · Stock Option (right to buy) | +5,636 | 5,636 | D | ||
Loading xslF345X06/ownership.xml…